Rebuttal from Dr van Meerbeeck

Jan P. van Meerbeeck


We agree that CT-scan is currently the most sensitive tool to screen for early stage lung cancer and that the population of radically treated patients has the highest risk of developing another lung cancer. We however have the following serious concerns about the immediate and widespread implementation of yearly CT-scan surveillance as advocated by WC Hanna (1):